GERN (STOCKS)
Geron Corp
$1.620000
+0.010000 (+0.62%)
Prev close: $1.610000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Harout Semerjian
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,037.33M
- Employees
- 229
- P/E (TTM)
- -13.56
- P/B (TTM)
- 4.18
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.03 | $-0.03 | +0.0037 | +10.98% |
|
Jun 2025 (Q2)
|
$-0.02 | $-0.03 | +0.0111 | +35.69% |
|
Mar 2025 (Q1)
|
$-0.03 | $-0.04 | +0.0086 | +22.28% |
|
Dec 2024 (Q4)
|
$-0.04 | $-0.05 | +0.0062 | +13.42% |
Financial Statements
| Revenues | $183.40M |
| Benefits Costs and Expenses | $251.52M |
| Costs And Expenses | $246.50M |
| Operating Expenses | $246.50M |
| Selling, General, and Administrative Expenses | $160.96M |
| Depreciation and Amortization | $529.00K |
| Other Operating Expenses | $85.01M |
| Operating Income/Loss | -$63.10M |
| Income/Loss From Continuing Operations After Tax | -$80.39M |
| Income/Loss From Continuing Operations Before Tax | -$68.11M |
| Net Income/Loss | -$79.99M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$79.99M |
| Net Income/Loss Available To Common Stockholders, Basic | -$79.99M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.12 |
| Diluted Earnings Per Share | -$0.12 |
| Basic Average Shares | 672,496,545 |
| Diluted Average Shares | 672,496,545 |
| Assets | $567.38M |
| Current Assets | $522.34M |
| Inventory | $95.42M |
| Other Current Assets | $426.92M |
| Noncurrent Assets | $45.04M |
| Fixed Assets | $973.00K |
| Other Non-current Assets | $44.07M |
| Liabilities | $318.68M |
| Current Liabilities | $87.71M |
| Accounts Payable | $11.11M |
| Wages | $16.39M |
| Other Current Liabilities | $60.21M |
| Noncurrent Liabilities | $230.96M |
| Equity | $248.71M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $248.71M |
| Liabilities And Equity | $567.38M |
| Net Cash Flow From Operating Activities | -$132.92M |
| Net Cash Flow From Operating Activities, Continuing | -$132.92M |
| Net Cash Flow From Investing Activities | -$17.41M |
| Net Cash Flow From Investing Activities, Continuing | -$17.41M |
| Net Cash Flow From Financing Activities | $168.05M |
| Net Cash Flow From Financing Activities, Continuing | $168.05M |
| Net Cash Flow | $17.81M |
| Net Cash Flow, Continuing | $17.73M |
| Comprehensive Income/Loss | -$80.60M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$80.60M |
| Other Comprehensive Income/Loss | $93.97M |